ACM
NUVB icon

ADAR1 Capital Management’s Nuvation Bio NUVB Stock Holding History

ADAR1 Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,500
Closed -$187K – 325
2026
Q1 		$187K Buy
+43,500
New +$242K 0.01% 262

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ADAR1 Capital Management's NUVB Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 43,500 shares — an estimated $187K sold.

ADAR1 Capital Management first reported a position in NUVB in Q1 2026 and held it in 1 quarter. The position peaked at $187K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • ADAR1 Capital Management reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 43,500 Nuvation Bio shares in Q2 2026, an estimated $187K.
  • ADAR1 Capital Management first reported a position in Nuvation Bio in Q1 2026 and held it in 1 quarter.
  • ADAR1 Capital Management's Nuvation Bio position peaked at $187K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.